Prostate cancer is one of the most common types of cancer that affects men. Understanding what it is, who is at risk and how it can be treated is important for staying healthy. The prostate is a small ...
News-Medical.Net on MSN
PSA-based tool improves decision making for prostate cancer screening and treatment
In a previous study, the researchers showed that PSA scores can impact both doctor and patient behavior, leading to biopsy ...
9don MSN
Easy-to-use tool can identify high- and low-risk metastatic prostate cancer patients earlier
A new study published in Nature Communications provides a framework for researching whether earlier, model-guided treatment ...
This is an opinion column. Get my weekly newsletter, The Barbershop. Sign up here for free! Rarely does Alabama have the opportunity to crash the top 10 among states in anything — unless we’re talking ...
“This study adjusted for testosterone levels, which can influence PSA and outcomes, and still found a significant association. This strengthens the argument that PSA response to neoadjuvant therapy is ...
California-based Artera, a company that develops multimodal AI-based prognostic and predictive cancer tests, has been granted de novo authorization by the FDA for its AI tool for prostate cancer ...
PSMA PET-CT is a diagnosit tool helping save men's lives with prostate cancer that has spread beyond the prostate gland Dr. David Samadi says that men with aggressive prostate cancer or a very high ...
Thanks to early detection and aggressive treatment for prostate cancer, 97 percent of all men diagnosed with the disease will survive at least 5 years and nearly 80 percent will survive at least a ...
The US FDA has granted De Novo marketing authorization for ArteraAI Prostate (Artera, Los Altos, California), a novel artificial intelligence (AI)-powered risk-stratification tool for patients with ...
The NHS is embarking on a trial that could cut prostate cancer diagnosis times from weeks to a single day. The initiative uses artificial intelligence to analyze MRI scans, potentially transforming ...
SYRACUSE, N.Y.--(BUSINESS WIRE)--Associated Medical Professionals (A.M.P.) announced today the availability of the ArteraAI Prostate Test, an AI-powered risk stratification tool to help personalize ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results